Cancer performance against the 62-day target was the best since August 2021, increasing to 61.9%, compared to 60.2% the previous month.
Y perfformiad ym maes canser yn erbyn y targed o 62 diwrnod oedd y gorau ers Awst 2021, gan gynyddu i 61.9%, o'i gymharu â 60.2% y mis blaenorol.